For vaginal health and balance.
Respecta® Balance Gel is a medical device adjuvant in the treatment of vaginitis and vaginosis specifically studied for rebalancing the physiological pH and vaginal microbiota.
The vaginal environment is populated by numerous bacterial species (such as lactobacilli, gardnerella, streptococci, etc.) that in physiological conditions are in balance (eubiosis) with a clear prevalence of lactobacilli. However, this fine balance can be altered by several factors including antibiotic consumption, use of overly aggressive cleansers, irritative or allergic conditions. Consequently, potentially pathogenic microorganisms such as Candida and Gardnerella take over the Lactobacillus population, creating a state of dysbiosis up to causing pathological conditions such as bacterial vaginosis, aerobic vaginitis or vulva-vaginitis caused by Candida spp. (VVC). In particular, in case of dysbiosis, vaginal pH often increases creating a vicious circle with a progressive reduction of the defenses of the vaginal mucosa.
Respecta® Balance Gel is suitable for restoring the physiological vaginal pH, favoring the proliferation and growth of beneficial microorganisms (lactobacilli) that normally colonize healthy tissue.
Glycogen, prebiotic fiber, hyaluronic acid and lactic acid.
In vitro mechanistic study.
*Registered as “Respecta® Gel Vaginale (NB 0476)”.
Product name | Respecta® Balance Gel* |
Status | Medical device class IIa |
Key ingredients | Glycogen, prebiotic fiber, hyaluronic acid and lactic acid |
Target and indication | Adjuvant in the treatment of vaginitis and vaginosis |
Claims EFSA | n. a. |
Scientific evidence and study | Mechanistic study |
Pharmaceutical form | Gel (single-use tubes or tube with vaginal applicator) |